Published in:
Open Access
01-12-2010 | Research article
Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis
Authors:
Cornelia Blaser, Matthias Klein, Denis Grandgirard, Matthias Wittwer, Heikki Peltola, Michael Weigand, Uwe Koedel, Stephen L Leib
Published in:
BMC Infectious Diseases
|
Issue 1/2010
Login to get access
Abstract
Background
Bacterial meningitis in children causes high rates of mortality and morbidity. In a recent clinical trial, oral glycerol significantly reduced severe neurological sequelae in paediatric meningitis caused by Haemophilus influenzae type b, and a tendency towards a benefit of adjunctive glycerol was seen in pneumococcal meningitis.
Methods
Here we examined the effects of glycerol in pneumococcal meningitis of infant rats and adult mice. All animals received ceftriaxone, and glycerol or placebo. Brain damage, hearing loss, and inflammatory parameters were assessed.
Results
Clinically and by histopathology, animals treated with glycerol or placebo did not differ. While both groups showed equally high levels of matrix metalloproteinase-9 at 24 h after infection, a significant difference in favour of glycerol was observed at 40 h after infection. However, this difference in matrix metalloproteinase-9 in late disease did not result in an improvement of histopathologic parameters.
Conclusion
No benefit of adjunctive glycerol was found in these models of pneumococcal meningitis.